China Pharma Holdings, Inc. (CPHI) income statement
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.52−0.04 (-7.47%)
Close on Nov 13, 2026Market cap $22.29MP/E –Yield –
China Pharma Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 11.8%
- Operating margin
- -111.8%
- Net margin
- -114.3%
- Return on equity, FY2025
- -20.9%
Financial strength
- Current ratio
- 0.26
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 4.0%
Valuation
- P/E ratio
- –
- Price to sales
- 5.69
- Price to book
- 0.62
- Dividend yield
- –
See a number that looks wrong?